Predictions
Inventiva SA
Start price
Target price
Perf. (%)
€3.71
17.03.24
17.03.24
€5.00
31.01.26
31.01.26
-2.70%
19.03.24
19.03.24
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€8.01
05.09.22
05.09.22
-
05.10.26
05.10.26
-57.57%
11.03.24
11.03.24
Probably not worthwhile Investment
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€1.51
27.11.23
27.11.23
-
27.11.24
27.11.24
4.25%
11.12.23
11.12.23
Probably not worthwhile Investment
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€2.10
01.11.23
01.11.23
€2.50
01.11.24
01.11.24
-25.24%
09.12.23
09.12.23
Could be worthwhile Investment >10% per year
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€2.81
24.12.22
24.12.22
-
24.12.23
24.12.23
-25.37%
01.11.23
01.11.23
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€6.02
27.10.22
27.10.22
-
27.10.23
27.10.23
-42.03%
28.10.23
28.10.23
Could be worthwhile Investment >10% per year
Abivax S.A.
Start price
Target price
Perf. (%)
€9.10
04.08.22
04.08.22
-
04.08.23
04.08.23
81.32%
05.08.23
05.08.23
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€9.82
21.07.22
21.07.22
-
21.07.23
21.07.23
-30.16%
22.07.23
22.07.23
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Poxel S.A.
Start price
Target price
Perf. (%)
€2.49
20.08.22
20.08.22
-
20.08.23
20.08.23
-75.54%
07.06.23
07.06.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€10.23
09.08.22
09.08.22
€14.00
09.08.23
09.08.23
-46.91%
30.05.23
30.05.23
Small cyclical dependencies
Below average Marketposition
Few uniques
Abivax S.A.
Start price
Target price
Perf. (%)
€8.30
02.09.22
02.09.22
€5.00
31.12.24
31.12.24
85.30%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Innate Pharma
Start price
Target price
Perf. (%)
€2.51
07.03.22
07.03.22
-
07.03.23
07.03.23
21.39%
08.03.23
08.03.23
Probably not worthwhile Investment
Innate Pharma
Start price
Target price
Perf. (%)
€3.24
10.02.22
10.02.22
€3.80
10.02.23
10.02.23
-4.81%
11.02.23
11.02.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€1.11
01.02.23
01.02.23
-
01.02.24
01.02.24
-0.36%
05.02.23
05.02.23
Risky Investment
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€5.24
27.11.21
27.11.21
€8.00
27.11.22
27.11.22
-47.90%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Onxeo S.A.
Start price
Target price
Perf. (%)
€0.41
27.11.21
27.11.21
€0.60
27.11.22
27.11.22
-56.65%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Boiron S.A.
Start price
Target price
Perf. (%)
€38.05
26.11.21
26.11.21
-
26.11.22
26.11.22
18.79%
27.11.22
27.11.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.60
30.03.22
30.03.22
-
30.03.23
30.03.23
-55.74%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.24
19.11.21
19.11.21
€2.60
19.11.22
19.11.22
-69.80%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
AB Science S.A.
Start price
Target price
Perf. (%)
€12.40
19.11.21
19.11.21
€13.60
19.11.22
19.11.22
-34.44%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
Nanobiotix
Start price
Target price
Perf. (%)
€8.51
11.11.21
11.11.21
€10.00
11.11.22
11.11.22
-53.17%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year